title: False-positive Xpert(®) MTB/RIF more than seven years after cure.
authors.affiliation: Department of Infectious Diseases, Northwick Park Hospital, London, UK. danny.r.stevenson@gmail.com.
authors.forename: D R
authors.initials: DR
authors.lastname: Stevenson
authors.affiliation: Department of Infectious Diseases, Northwick Park Hospital, London, UK.
authors.forename: J R
authors.initials: JR
authors.lastname: Biswas
authors.affiliation: Department of Infectious Diseases, Northwick Park Hospital, London, UK.
authors.forename: A
authors.initials: A
authors.lastname: Lievesley
authors.affiliation: Department of Infectious Diseases, Northwick Park Hospital, London, UK.
authors.forename: G
authors.initials: G
authors.lastname: Quinn
authors.affiliation: Department of Infectious Diseases, Northwick Park Hospital, London, UK.
authors.forename: J
authors.initials: J
authors.lastname: Buckley
authors.affiliation: Department of Infectious Diseases, Northwick Park Hospital, London, UK.
authors.forename: L
authors.initials: L
authors.lastname: John
authors.affiliation: Department of Infectious Diseases, Northwick Park Hospital, London, UK.
authors.forename: R N
authors.initials: RN
authors.lastname: Davidson
mesh_terms: D000904:Antibiotics, Antitubercular / Q000627:therapeutic use*; D024881:Drug Resistance, Bacterial; D005260:Female; D006801:Humans; D009169:Mycobacterium tuberculosis / Q000187:drug effects* / Q000302:isolation & purification*; D021141:Nucleic Acid Amplification Techniques / Q000379:methods*; D012141:Respiratory Tract Infections / Q000175:diagnosis*; D012293:Rifampin / Q000627:therapeutic use*; D014376:Tuberculosis / Q000175:diagnosis*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
chemical_list: D000904:Antibiotics, Antitubercular; D012293:Rifampin